pindolol tablet
carilion materials management - pindolol (unii: bj4hf6iu1d) (pindolol - unii:bj4hf6iu1d) - pindolol tablets are indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. pindolol tablets are contraindicated in: 1) bronchial asthma; 2) overt cardiac failure; 3) cardiogenic shock; 4) second and third degree heart block; 5) severe bradycardia. (see warnings.)
pindolol tablet
carilion materials management - pindolol (unii: bj4hf6iu1d) (pindolol - unii:bj4hf6iu1d) - pindolol tablets are indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. pindolol tablets are contraindicated in: 1) bronchial asthma; 2) overt cardiac failure; 3) cardiogenic shock; 4) second and third degree heart block; 5) severe bradycardia. (see warnings.)
pindolol tablets 5mg "nichiiko" (ピンドロール錠5mg「日医工」)
nichi-iko pharmaceutical co.,ltd - pindolol - white tablet, diameter: 7.0 mm, thickness: 2.4 mm
visken- pindolol tablet
novartis pharmaceuticals corporation - pindolol (unii: bj4hf6iu1d) (pindolol - unii:bj4hf6iu1d) - tablet - 5 mg - visken® (pindolol) is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. visken® (pindolol) is contraindicated in: 1) bronchial asthma; 2) overt cardiac failure; 3) cardiogenic shock; 4) second and third degree heart block; 5) severe bradycardia. (see warnings)
barbloc 15 tablet
alphapharm pty ltd - pindolol -
pindolol -dr-6544 5mg tablet
novartis healthcare phils inc - pindolol - tablet - 5mg
barbloc 5 tablet
alphapharm pty ltd - pindolol, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica - indications as at 18 november 2004: hypertension (either alone or in combination with other antihypertensive drugs). angina pectoris (prevention of attacks). cardiac arrhythmias [sinus tachycardia, paroxysmal tachycardia, supraventricular and ventricular extrasystoles, drug induced extrasystoles (digitalis), atrial flutter and fibrillation - to slow the ventricular rate]. functional hyperadrenergic cardiac disturbances (hyperkinetic heart syndrome, neurocirculatory asthenia).
visken 5 mg tabl.
novartis pharma sa-nv - pindolol 5 mg - tablet - 5 mg - pindolol 5 mg - pindolol
visken tablet
xediton pharmaceuticals inc - pindolol - tablet - 5mg - pindolol 5mg - beta-adrenergic blocking agents